GENNEX LABORATORIES
Smallcap | BSE
Sector
Here's the live share price of Gennex Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-2.61₹ -0.32
As on Feb 16, 2026, 4:01 PM IST
Gennex Laboratories Price Performance
Today's LowToday's High
₹11.80₹12.50
₹11.94
52 Weeks' Low52 Weeks' High
₹10.84₹17.25
₹11.94
Open Price
₹12.39
Prev. Close
₹12.26
Volume
4,73,359
Over the last 5 years, the share price of Gennex Laboratories has gained 17.94% CAGR. Over the past year, the corresponding return has been -5.61%.
Gennex Laboratories’s current P/E of 12.98x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Gennex Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Gennex Laboratories | -1.73 | -12.53 | -24.24 | -1.49 | -5.61 | 29.56 | 17.94 |
| Sun Pharmaceutical Industries | 0.52 | 0.17 | -3.01 | 3.70 | -0.07 | 19.19 | 22.11 |
| Divi's Laboratories | 2.14 | -3.19 | -5.49 | 0.39 | 5.44 | 30.15 | 10.65 |
| Torrent Pharmaceuticals | 8.00 | 6.24 | 10.81 | 17.47 | 41.29 | 41.20 | 26.71 |
| Cipla | 1.97 | -5.41 | -11.40 | -13.22 | -6.99 | 9.68 | 9.95 |
| Dr. Reddy's Laboratories | 2.12 | 6.83 | 1.81 | 0.65 | 5.99 | 11.75 | 6.11 |
| Lupin | 2.22 | 0.98 | 7.85 | 13.10 | 12.60 | 49.56 | 15.93 |
| Zydus Lifesciences | 2.49 | 2.94 | -3.60 | -7.97 | 0.93 | 24.39 | 14.29 |
| Mankind Pharma | 0.99 | -7.30 | -8.24 | -15.87 | -13.22 | 13.46 | 7.87 |
| Aurobindo Pharma | -0.60 | 0.32 | -3.10 | 9.34 | 4.80 | 35.81 | 4.90 |
| Alkem Laboratories | -3.68 | -6.06 | -4.35 | 2.43 | 17.66 | 18.54 | 13.66 |
| Biocon | 4.24 | 0.44 | -7.37 | 5.94 | 9.13 | 17.46 | -1.36 |
| Glenmark Pharmaceuticals | 4.89 | 0.87 | 6.92 | -0.74 | 53.55 | 67.80 | 32.83 |
| Abbott India | -3.74 | -5.55 | -9.83 | -20.72 | -5.42 | 9.08 | 12.77 |
| Laurus Labs | 6.36 | -7.33 | 1.33 | 17.66 | 85.00 | 45.09 | 22.35 |
| GlaxoSmithKline Pharmaceuticals | 4.38 | 8.43 | 4.71 | -6.28 | 28.59 | 27.72 | 12.61 |
| Anthem Biosciences | 5.33 | 10.52 | 1.36 | -16.68 | -5.78 | -1.97 | -1.18 |
| Ipca Laboratories | 5.83 | -0.58 | 0.86 | 10.19 | 3.11 | 21.19 | 9.71 |
| Ajanta Pharma | 2.63 | 8.17 | 16.03 | 9.12 | 14.42 | 33.69 | 19.43 |
| J B Chemicals & Pharmaceuticals | 6.65 | 4.19 | 8.18 | 15.12 | 18.43 | 26.10 | 26.01 |
Over the last one year, Gennex Laboratories has declined 5.61% compared to peers like Sun Pharmaceutical Industries (-0.07%), Divi's Laboratories (5.44%), Torrent Pharmaceuticals (41.29%). From a 5 year perspective, Gennex Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (22.11%) and Divi's Laboratories (10.65%).
Gennex Laboratories Financials
Gennex Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 12.34 | 12.31 |
| 10 | 12.32 | 12.36 |
| 20 | 12.46 | 12.55 |
| 50 | 13.01 | 12.97 |
| 100 | 13.48 | 13.19 |
| 200 | 13.11 | 13.52 |
Gennex Laboratories Share Holding Pattern
In the latest quarter, Gennex Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 76.39% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Gennex Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Feb 14, 2026, 11:42 PM IST | Gennex Laboratories - Intimation Of Reconstitution Of Audit Committee, Stakeholders Relationship Committee And Nomination And |
| Feb 14, 2026, 11:25 PM IST | Gennex Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
| Feb 14, 2026, 10:56 PM IST | Gennex Laboratories - Announcement under Regulation 30 (LODR)-Resignation of Director |
| Feb 14, 2026, 10:30 PM IST | Gennex Laboratories - Quarter And Nine Months Ended December 31, 2025 |
| Feb 14, 2026, 10:23 PM IST | Gennex Laboratories - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter And Nin |
About Gennex Laboratories
Gennex Laboratories Ltd. is a Public Limited Listed company incorporated on 29/03/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1990PLC011168 and registration number is 011168. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 94.58 Cr. and Equity Capital is Rs. 22.74 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressSy. No.133, Sangareddy Dist. Telangana 502325
- Contact
Management
- Mr. Arihant BaidManaging Director
- Dr. A R R PantuluNon Executive Director
- Mr. Sandeep Kumar DagaNon Executive Director
- Mr. A S Nageswar RaoIndependent Director
- Mr. Dilip Raj SinghviIndependent Director
- Ms. Shilpa BungIndependent Woman Director
FAQs on Gennex Laboratories Share Price
What is the share price of Gennex Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Gennex Laboratories is ₹11.94 as on Feb 16, 2026.
What kind of stock is Gennex Laboratories?
The Gennex Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Gennex Laboratories?
The market cap of Gennex Laboratories is ₹290.08 Cr as on Feb 16, 2026.
What are today's High and Low prices of Gennex Laboratories?
Today’s highest and lowest price of Gennex Laboratories are ₹12.50 and ₹11.80.
What are the 52 Week High and 52 Week Low of Gennex Laboratories?
The 52-week high/low is the highest and lowest price at which Gennex Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Gennex Laboratories is ₹17.25 and 52-week low of Gennex Laboratories is ₹10.84 as on Feb 16, 2026.
How has the Gennex Laboratories performed historically in terms of returns?
The Gennex Laboratories has shown returns of -2.61% over the past day, -12.53% for the past month, -24.24% over 3 months, -5.61% over 1 year, 29.56% across 3 years, and 17.94% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Gennex Laboratories?
P/E ratio of and PB ratio of Gennex Laboratories are 12.98 and 1.36 on Feb 16, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse